Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with ImatinibLaura Cesini, Roberto Latagliata, Ida Carmosino et al.|Oncology Research and Treatment|2019Cited by 9
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?Roberto Latagliata, Robin Foà, Massimo Breccia et al.|European Journal Of Haematology|2018Cited by 6
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practiceAnna Maria Frustaci, Lara Crucitti, Claudia Baratè et al.|Haematologica|2025Cited by 2